featured
Complete Clearance and Psoriasis Area and Severity Index Response for Brodalumab and Ustekinumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Complete Clearance and Psoriasis Area and Severity Index Response for Brodalumab and Ustekinumab in AMAGINE-2 and -3
J Eur Acad Dermatol Venereol 2020 Jul 14;[EPub Ahead of Print], RB Warren, JB Hansen, K Reich, C Paul, L PuigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.